These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2584142)

  • 41. Production of a novel FK520 analog in Streptomyces hygroscopicus: improving titer while minimizing impurities.
    Regentin R; Cadapan L; Ou S; Zavala S; Licari P
    J Ind Microbiol Biotechnol; 2002 Jan; 28(1):12-6. PubMed ID: 11938465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pironetin, a novel plant growth regulator produced by Streptomyces sp. NK10958. I. Taxonomy, production, isolation and preliminary characterization.
    Kobayashi S; Tsuchiya K; Harada T; Nishide M; Kurokawa T; Nakagawa T; Shimada N; Kobayashi K
    J Antibiot (Tokyo); 1994 Jun; 47(6):697-702. PubMed ID: 8040075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production of 17-O-demethyl-geldanamycin, a cytotoxic ansamycin polyketide, by Streptomyces hygroscopicus DEM20745.
    Baksh A; Kepplinger B; Isah HA; Probert MR; Clegg W; Wills C; Goodfellow M; Errington J; Allenby N; Hall MJ
    Nat Prod Res; 2017 Aug; 31(16):1895-1900. PubMed ID: 27966376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of FK409 on small bowel ischemia-reperfusion injury in dogs.
    Kawata K; Takeyoshi I; Iwanami K; Sunose Y; Aiba M; Ohwada S; Matsumoto K; Morishita Y
    Transplant Proc; 2001; 33(1-2):883. PubMed ID: 11267113
    [No Abstract]   [Full Text] [Related]  

  • 45. 834-B1, a new thiolactone containing antibiotic taxonomy, fermentation, isolation and structure.
    Sato T; Suzuki K; Kadota S; Abe K; Takamura S; Iwanami M
    J Antibiot (Tokyo); 1989 Jun; 42(6):890-6. PubMed ID: 2737948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eurystatins A and B, new prolyl endopeptidase inhibitors. III. Fermentation and controlled biosynthesis of eurystatin analogs by Streptomyces eurythermus.
    Suzuki K; Toda S; Furumai T; Fukagawa Y; Oki T
    J Antibiot (Tokyo); 1994 Sep; 47(9):982-91. PubMed ID: 7928700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mer-A2026A and B, novel piericidins with vasodilating effect. I. Producing organism, fermentation, isolation and biological properties.
    Kominato K; Watanabe Y; Hirano S; Kioka T; Terasawa T; Yoshioka T; Okamura K; Tone H
    J Antibiot (Tokyo); 1995 Feb; 48(2):99-102. PubMed ID: 7706135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FK409, a spontaneous nitric oxide releaser, attenuates allograft vasculopathy in a rat aortic transplant model.
    Fukada J; Schena S; Tack I; Ruiz P; Kurimoto Y; Pang M; Aitouche A; Abe T; Striker LJ; Pham SM
    Circ Res; 2000 Jul; 87(1):66-72. PubMed ID: 10884374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DC-86-M, a novel antitumor antibiotic. I. Taxonomy of producing organism and fermentation.
    Asano K; Takahashi K; Tomita F; Kawamoto I
    J Antibiot (Tokyo); 1986 May; 39(5):619-23. PubMed ID: 3733510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three novel cyclic hexapeptides from Streptomyces alboflavus 313 and their antibacterial activity.
    Ji Z; Wei S; Fan L; Wu W
    Eur J Med Chem; 2012 Apr; 50():296-303. PubMed ID: 22365561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New milbemycins from Streptomyces hygroscopicus subsp. aureolacrimosus: fermantation, isolation and strucutre elucidation.
    Nonaka K; Tsukiyama T; Okamoto Y; Sato K; Kumasaka C; Yammoto T; Maruyama F; Yoshikawa H
    J Antibiot (Tokyo); 2000 Jul; 53(7):694-704. PubMed ID: 10994811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue.
    Hirasawa Y; Nishio M; Maeda K; Yoshida K; Kita Y
    Eur J Pharmacol; 1995 Jan; 272(1):39-43. PubMed ID: 7713147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new topoisomerase-II inhibitor, BE-10988, produced by a streptomycete. I. Taxonomy, fermentation, isolation and characterization.
    Oka H; Yoshinari T; Murai T; Kawamura K; Satoh F; Funaishi K; Okura A; Suda H; Okanishi M; Shizuri Y
    J Antibiot (Tokyo); 1991 May; 44(5):486-91. PubMed ID: 1648054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SW-163C and E, novel antitumor depsipeptides produced by Streptomyces sp. I. Taxonomy, fermentation, isolation and biological activities.
    Kurosawa K; Takahashi K; Tsuda E
    J Antibiot (Tokyo); 2001 Aug; 54(8):615-21. PubMed ID: 11592497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Luminacins: a family of capillary tube formation inhibitors from Streptomyces sp. I. Taxomony, fermentation, isolation, physico-chemical properties and structure elucidation.
    Naruse N; Kageyama-Kawase R; Funahashi Y; Wakabayashi T
    J Antibiot (Tokyo); 2000 Jun; 53(6):579-90. PubMed ID: 10966073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of pre- and post-ischemic treatments with FK409, a nitric oxide donor, on ischemia/reperfusion-induced renal injury and endothelin-1 production in rats.
    Nakajima A; Ueda K; Takaoka M; Kurata H; Takayama J; Ohkita M; Matsumura Y
    Biol Pharm Bull; 2006 Mar; 29(3):577-9. PubMed ID: 16508172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FR-900148, a new antibiotic. I. Taxonomy, fermentation, isolation and characterization.
    Kuroda Y; Okuhara M; Goto T; Yamashita M; Iguchi E; Kohsaka M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1980 Mar; 33(3):259-66. PubMed ID: 6897940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on novel HIF activators, A-503451s.I. Producing organism, fermentation, isolation and structural elucidation.
    Hirota-Takahata Y; Kobayashi H; Kizuka M; Ohyama T; Kitamura-Miyazaki M; Suzuki Y; Fujiwara M; Nakajima M; Ando O
    J Antibiot (Tokyo); 2016 Oct; 69(10):747-753. PubMed ID: 26956789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interaction of FK409, a novel nitric oxide releaser, and peripherally administered morphine during experimental inflammation.
    Nozaki-Taguchi N; Yamamoto T
    Anesth Analg; 1998 Feb; 86(2):367-73. PubMed ID: 9459250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of ascorbic acid for raising clinical response to long-acting nitrates].
    Vodoevich VP; Vinogradova TA; Serafimovich IA; Stepuro II; Chaĭkovskaia NA; Vinogradov VV
    Klin Med (Mosk); 2002; 80(11):55-8. PubMed ID: 12516344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.